New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...

Future trial results investigating the role of ivonescimab in patients ... advisory board participation for Eli Lilly, MSD, ...

Worth noting, CVS Caremark—the biggest PBM in the U.S.— announced in May that it would make Novo Nordisk’s rival drug Wegovy ...

The Big Pharma mainstay blew away EPS and revenue expectations when it reported Q3 financials, with management raising ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

The Eli Lilly and Company will acquire Adverum Biotechnologies, according to a joint press release issued by the 2 companies.

The investment, which will expand Eli Lilly’s existing campus in Puerto Rico, is slated to create 100 new jobs, on top of ...

Physical function decline is an increasingly recognised concern among individuals with long-term conditions such as Type 2 ...

The Hollywood star sat down with Newsweek to discuss his next big project: upping enrollment in clinical trials.

Eli Lilly and Company said the partnership will result in the build of the most powerful supercomputer owned by a ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...

Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...